title: Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII.
authors.affiliation: Department of Anesthesiology and Pain Medicine, University of Alberta, Edmonton, Canada.
authors.forename: Stephan
authors.initials: S
authors.lastname: Malherbe
authors.forename: Ban C H
authors.initials: BC
authors.lastname: Tsui
authors.forename: Kent
authors.initials: K
authors.lastname: Stobart
authors.forename: John
authors.initials: J
authors.lastname: Koller
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D001120:Arginine / Q000031:analogs & derivatives; D001026:Coronary Artery Bypass; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D007223:Infant; D008297:Male; D010875:Pipecolic Acids / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D011994:Recombinant Proteins / Q000627:therapeutic use*; D013449:Sulfonamides; D013921:Thrombocytopenia / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D010875:Pipecolic Acids; D011994:Recombinant Proteins; D013449:Sulfonamides; D005167:Factor VII; D006493:Heparin; D001120:Arginine; C103587:recombinant FVIIa; D015942:Factor VIIa; C031942:argatroban